Credit Insurance Boosts Swedish Companies’ Growth Amid Financial Uncertainty

Swedish companies increasingly adopt credit insurance to enhance financial stability and growth, supported by data-driven insights and strategic investment in life science innovation.

    Key details

  • • Credit insurance strengthens cash flow and balance sheets by securing customer payments.
  • • It enables companies to expand into new markets with reduced risk using real-time data insights.
  • • Atradius offers comprehensive risk reports and maintains a 95% customer retention rate.
  • • Flerie invests primarily in private life science firms, using an evergreen model and international networks to manage risk.

Amid a backdrop of rising credit risks, an increasing number of Swedish businesses are turning to credit insurance to safeguard their finances and support growth initiatives. Camilla Arwin, risk underwriting manager at Atradius and board member of the Credit and Guarantee Insurance Association (KGFF), highlights that credit insurance strengthens cash flow and balance sheets by ensuring that payments from customers are secured — either through direct customer payment or insurance coverage, reducing the need for loss provisions. This financial security empowers companies to enter new markets confidently, mitigating risks associated with expansion.

Credit insurance also leverages real-time, data-driven insights for improved credit assessments, moving beyond traditional, outdated reports. CFOs receive actionable intelligence to evaluate customer reliability and adjust payment terms effectively. Furthermore, the product offers flexibility for rapid responses to evolving global risk conditions, helping to prevent ripple effects from disruptions.

Atradius, a leader in credit insurance operating in over 50 countries with a 95% customer retention rate, provides clients with valuable risk reports and tools that facilitate exploration of new business opportunities and informed market entry decisions.

In parallel, investment firm Flerie, with a portfolio primarily invested in private life science companies in Sweden and internationally, continues to provide stable exposure to innovation for investors. Led by CEO Ted Fjällman, Flerie adopts an evergreen model supporting companies across various therapeutic areas and development stages, emphasizing proactive risk management and international syndicate collaboration.

This simultaneous emphasis on risk mitigation through credit insurance and strategic investment in high-growth sectors reflects a broader trend among Swedish companies seeking secure, data-backed financial strategies to navigate uncertainty and fuel expansion.

This article was synthesized and translated from native language sources to provide English-speaking readers with local perspectives.

The top news stories in Sweden

Delivered straight to your inbox each morning.